BNP Paribas Financial Markets Acquires New Position in Viemed Healthcare, Inc. (NASDAQ:VMD)

BNP Paribas Financial Markets acquired a new position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 47,118 shares of the company's stock, valued at approximately $378,000. BNP Paribas Financial Markets owned about 0.12% of Viemed Healthcare as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. R Squared Ltd bought a new stake in shares of Viemed Healthcare in the 4th quarter worth approximately $41,000. EntryPoint Capital LLC purchased a new position in shares of Viemed Healthcare in the fourth quarter worth $92,000. Prudential Financial Inc. purchased a new position in shares of Viemed Healthcare in the fourth quarter worth $93,000. Oxford Asset Management LLP purchased a new position in shares of Viemed Healthcare in the fourth quarter worth $98,000. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Viemed Healthcare by 18.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,005 shares of the company's stock worth $105,000 after buying an additional 1,997 shares during the period. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Trading Down 0.6%

Shares of NASDAQ VMD traded down $0.04 during trading hours on Friday, hitting $6.53. The company's stock had a trading volume of 3,594 shares, compared to its average volume of 139,373. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The stock has a market cap of $258.09 million, a price-to-earnings ratio of 24.19 and a beta of 1.49. Viemed Healthcare, Inc. has a 12 month low of $6.14 and a 12 month high of $9.81. The business has a 50-day simple moving average of $6.83 and a 200-day simple moving average of $7.70.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.06. The business had revenue of $59.10 million for the quarter, compared to the consensus estimate of $60.60 million. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.